Securing the supply of benzathine penicillin: a global perspective on risks and mitigation strategies to prevent future shortages
-
10 03 2023
Source: Int Health.
Details:
-
Alternative Title:Int Health
-
Personal Author:
-
Description:Benzathine benzylpenicillin is a globally indispensable medicine. As a long-lasting injectable penicillin, it serves as the primary treatment for syphilis, group A streptococcal infections, rheumatic fever and rheumatic heart disease. A competitive market and low profit margins, compounded by limited visibility of demand, have resulted in a decreased number of active pharmaceutical ingredient (API) manufacturers. By 2016, only three Chinese API manufacturers remained, continuing to supply to the global market today. Recurring global shortages, a consequence of supply and demand imbalances, indicate underlying market risks. Therefore, the need for mitigation strategies is imperative.
-
Keywords:
-
Source:
-
Pubmed ID:37787149
-
Pubmed Central ID:PMC10987389
-
Document Type:
-
Funding:
-
Collection(s):
-
Main Document Checksum:
-
File Type:
-
Supporting Files:No Additional Files
More +